Fred Alger Management LLC Has $301.81 Million Position in Astera Labs, Inc. $ALAB

Fred Alger Management LLC lessened its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 13.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,541,438 shares of the company’s stock after selling 242,898 shares during the period. Astera Labs accounts for about 1.2% of Fred Alger Management LLC’s portfolio, making the stock its 18th largest position. Fred Alger Management LLC owned 0.91% of Astera Labs worth $301,814,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Assetmark Inc. lifted its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares in the last quarter. Advisors Asset Management Inc. grew its holdings in Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after acquiring an additional 194 shares during the last quarter. Manchester Capital Management LLC increased its position in Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after acquiring an additional 283 shares in the last quarter. Pinpoint Asset Management Singapore Pte. Ltd. bought a new position in shares of Astera Labs in the third quarter worth about $47,000. Finally, Whittier Trust Co. bought a new position in shares of Astera Labs in the third quarter worth about $55,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Jitendra Mohan sold 94,971 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the transaction, the chief executive officer directly owned 1,452,739 shares in the company, valued at $179,863,615.59. This trade represents a 6.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Michael Truett Tate sold 12,001 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the completion of the transaction, the chief financial officer owned 192,083 shares in the company, valued at $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 224,292 shares of company stock worth $27,676,069. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Trading Up 0.3%

Shares of NASDAQ ALAB opened at $120.31 on Monday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm’s 50-day moving average is $147.89 and its 200-day moving average is $168.03. The firm has a market capitalization of $20.48 billion, a PE ratio of 98.61, a price-to-earnings-growth ratio of 2.37 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period in the previous year, the firm posted $0.37 earnings per share. Astera Labs’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on ALAB shares. Loop Capital began coverage on shares of Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Northland Securities increased their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Finally, Citigroup lowered their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $202.22.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.